Biotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of COVID-19 vaccines, dealing big losses to some hedge funds.
from MarketWatch.com - Top Stories https://ift.tt/3dq2Fzf
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3dq2Fzf
via IFTTT
Kommentare
Kommentar veröffentlichen